Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Biology

Background:

• 1,4-Naphthoquinone derivatives are investigated for their potential as antitumor agents.
• The 5,7-dimethoxyl moiety was incorporated to explore structure-activity relationships.
• Anticancer drug development requires novel compounds with improved efficacy and selectivity.

Purpose of the Study:

• To design, synthesize, and evaluate novel 1,4-naphthoquinone derivatives as antitumor agents.
• To investigate the structure-activity relationships of these compounds against various human cancer cell lines.
• To explore the mechanistic basis of the observed antiproliferative activity, including electrochemical properties and cellular effects.

Main Methods:

• Synthesis of 1,4-naphthoquinone derivatives bearing a 5,7-dimethoxyl group.
• Antiproliferative activity testing against five human cancer cell lines (A549, Hela, HepG2, NCI-H460, HL-60).
• Structure-activity relationship analysis, electrochemical evaluation, and mechanistic studies (apoptosis, cell cycle, ROS generation).

Main Results:

• All synthesized compounds demonstrated antiproliferative activity.
• The presence of a chlorine atom at the 2-position was critical for activity.
• Compound 9e exhibited significant anti-leukemic activity against HL-60 cells (IC50 = 3.8 μM) with low cytotoxicity to normal WI-38 cells (IC50 = 40.7 μM).
• Mechanistic studies on 9e revealed induction of apoptosis, G2/M phase arrest, and reactive oxygen species (ROS) generation.

Conclusions:

• The 2-chloro-1,4-naphthoquinone derivatives are promising candidates for anticancer drug development.
• Compound 9e shows significant potential for the treatment of promyelocytic leukemia.
• The observed activity is correlated with electrochemical properties and mediated by ROS generation and induction of apoptosis.